In our latest video, Mr Mende tells us how autoantibody determination completely changed his prognosis. For the past six years, Mr Mende has suffered from necrotising myositis, an autoimmune disease that mainly affects the connective tissue and muscles. Today he…
Read more
Availability of EUROIMMUN products in the EU secured On May 10, 2023, EUROIMMUN received the certificate for its quality management system according to the new European Regulation on in vitro diagnostic medical devices (EU) 2017/746 (IVDR) from TÜV Rheinland LGA…
Read more
As the capstone in a multi-year transformation process, on May 9th, our parent company unveiled its new name and brand – Revvity. For more than five years, EU…
Since 23 February 2022, residents of the district of Böblingen can receive one of 4000 free COVID-19 antibody tests offered by pharmacist Dr Björn Schittenhel…
With the Corporate COVID-19 Antibody Testing Program, EUROIMMUN gives companies the possibility to offer to their staff what EUROIMMUN has already offered to th…
Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 11th article by Prof Hans-Jürgen Tietz, Director of the Institut…